Cisterna Biologics Analysis: $500K Raised
What is Cisterna Biologics?
Cisterna Biologics develops high-quality mRNA for therapeutic applications, focusing on innovative production technologies to advance mRNA-based treatments.
Employees
2
Founded
2022
Investors
- Y Combinator
- National Science Foundation
Product Features & Capabilities
- dT-purified mRNA, SPECC-purified mRNA, high-quality mRNA for therapeutic applications, advanced mRNA production technology, solutions for mRNA-related impurities
How much Cisterna Biologics raised
1: - $500,000
August 22, 2022Lead Investor: Y Combinator, National Science Foundation
Market Focus
Cisterna Biologics primarily focuses on the biotechnology industry, specifically in the development and production of mRNA-based therapeutics.
Competitors Overview
Cisterna Biologics operates in the mRNA therapeutics market, which has several notable competitors. The main competitors include:
- Moderna, Inc.
- Overview: Known for its mRNA COVID-19 vaccine, SpikeVax, Moderna is a leader in mRNA technology and has a robust pipeline of mRNA-based t
See something that needs updating? Suggest edits to this profile.